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Abstract: Coagulation involves a complex set of events that are important in maintaining 
hemostasis. Biochemical interactions are classically known to regulate the hemostatic 
process, but recent evidence has revealed that mechanical interactions between platelets 
and their surroundings can also play a substantial role. Investigations into platelet 
mechanobiology have been challenging however, due to the small dimensions of platelets 
and their glycoprotein receptors. Platelet researchers have recently turned to 
microfabricated devices to control these physical, nanometer-scale interactions with a 
higher degree of precision. These approaches have enabled exciting, new insights into the 
molecular and biomechanical factors that affect platelets in clot formation. In this review, 
we highlight the new tools used to understand platelet mechanobiology and the roles of 
adhesion, shear flow, and retraction forces in clot formation. 
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1. Introduction  
Platelets are one of the smallest cells in the human body, having discoid shapes with 2–4 μm 
diameters, but they play a large role in preventing blood loss when damage has occurred in a vessel [1,2]. 
Platelets initiate hemostasis by using their glycoprotein receptors to form attachments to the damaged 
tissue, which arrests them from circulating in the blood (Figure 1a) [3,4]. Once attached, platelet 
release a variety of agonists and soluble adhesive proteins from within their granules to activate and 
recruit more platelets to the wound site (Figure 1b) [5]. Platelets can also act as biomechanical 
elements for the growing clot structure by using their glycoprotein receptors to form bridges between 
other platelets and the surrounding protein meshwork that forms the hemostatic plug (Figure 1c). They 
further reinforce the integrity of the plug by using their cytoskeletal filaments to undergo shape change 
[6,7], forming protrusions that enable more physical connections with other platelets within the clot, 
while also using their actin-myosin interactions to pull the clot into a more compact structure that 
stabilizes it against the vessel wall [8].  
Figure 1. Platelet Adhesion and Aggregation: (a) Platelets adhere to the vessel wall when 
exposed to matrix proteins. (b) Adhered platelets undergo shape change and release soluble 
adhesive proteins from their α-granules. (c) A hemostatic plug is formed when platelets 
adhere to fibrin and each other. Specific receptor-ligand bonds mediate (d) platelet 
adhesion and (e) platelet aggregation.  
 
Glycoprotein receptors in platelets bind to ligands sites found within the extracellular matrix (ECM) 
of the vessel wall and soluble adhesive proteins that platelets release [9]. ECM proteins of the vessel 
wall consist mainly of collagen and laminin, but soluble adhesive proteins like von Willebrand Factor Int. J. Mol. Sci. 2011, 12                 
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(vWF), fibrinogen, and fibronectin can also deposit onto the wound site to enhance platelet adhesion 
(Figure 1d) [10–13]. The initial arrest of a platelet from the blood flow involves the glycoprotein 
receptor GPIb-IX-V, but subsequent engagement of GPIV to collagen can activate integrins α2β1 and 
αIIbβ3, which further assist in the adhesion process. P-selectin receptors on the surface of activated 
endothelial cells can mediate platelet adhesion through interactions with P-selectin glycoprotein ligand 1 
(PSGL1) on a platelet’s membrane after degranulation [14,15]. Moreover, platelet GPIbα receptors can 
also interact with P-selectin to aid in homing platelets to the site of injury [16]. Receptor-ligand 
interactions are nano-scale and a single platelet can have a multitude of different receptor-ligand 
interactions during clot formation (Figure 1e). Understanding these small and complex interactions 
requires approaches that can specifically control the ligand presentation on a surface and have 
sufficient measurement sensitivity to interrogate their biophysical properties. 
Physical forces also play a critical role in hemostasis by regulating the mechanobiology of platelets. 
When a platelet adheres to a wound site, adhesive forces keep the platelet attached and prevent it from 
being dislodged by the blood stream. Receptors GPIb-IX-V and αIIbβ3 are known to have a large role in 
platelet mechanobiology because they regulate the initial tethering to the vessel wall and the activation 
of platelet shape change and force generation [17]. Upon activation, G-actin monomers in platelets 
polymerize into F-actin filaments, allowing platelets to undergo shape change. Platelet activation also 
leads to phosphorylation of non-muscle myosin, which can in turn, engage with actin and form 
contractile filaments. The contractile forces produced by platelets are in the range of piconewtons for a 
single actin-myosin complex to nanonewtons for single platelets, but are vastly important in stabilizing 
a clot by compacting its structure [18] and in strengthening platelet adhesions through integrin-related 
mechanotransduction [19]. Another type of force that is important in hemostasis is shear forces applied 
to platelets due to flow of blood. Shear forces can cause platelets to detach, but are also known to have 
a major role in the steps from platelet adhesion to aggregation.  
A multitude of engineered devices have been developed to look at adhesive, contractile, and shear 
forces and the role of agonist and receptor-ligand bindings on the clot formation process [5,20–25]. 
Among the technological advances for studying platelets, micro- and nano-scale tools have been used 
recently to understand platelet biology and thrombus formation dynamics [24,26,27]. The advantage of 
these tools is that platelets and their adhesion receptors are micro- and nano-scale is size, so devices 
that are in the same size range as platelets can be used as programmable materials, in which the 
physical and adhesive interactions between platelets and their surroundings can be controlled and 
measured. In this review, we will highlight the tools used to examine clot formation with an emphasis 
on the tools used to study the role of hemodynamic shear and platelet forces. 
2. Platelet-Shear Flow Interactions  
Early studies on platelet adhesion and aggregation were conducted in the absence of shear   
flow [28–30]. Soluble factors were assumed to be the main mechanisms driving hemostasis and that 
shear flow had a minor effect. These studies on platelets under static conditions examined the effect of 
different ECM proteins and biomaterials on platelet adhesion, shape change, and spreading, and the 
role of different agonists and inhibitors on platelet aggregation [30,31]. These studies were helpful in 
gaining a better understanding of the process, but shear forces were later recognized as having a more I
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identify the importance of vWF-GPIb and fibrinogen-αIIbβ3 interactions under higher shear   
rates [40–43]. The downside however was that since the adhesive wall was a vessel segment, platelets 
were exposed to the native ECM, which had an uncharacterized composition of ligands with which the 
platelets could interact, making it difficult to study specific receptor-ligand interactions. 
Tubular flow chambers allowed for better control over the adhesive interactions, but it did not have 
the same control over the shear rate as a result of the ex vivo nature of the assay. The typical setting of 
these assays consists of a tube coated with the targeted ECM or anticoagulant and surgically inserted 
between an artery and vein to form a shunt. This approach allowed for studies on platelet binding to 
surfaces with well-defined ECMs [44]. In addition, the tubular devices were helpful in studying drug 
effects on platelets due to the usage of blood in the absence of anticoagulants. Different synthetic graft 
and stent materials could be examined using these devices because of the particular bio-compatibility 
issues that they can introduce when exposed to the blood and the potential for clot formation possibly 
leading to restenosis, embolism, or other secondary defects [45–47].  
Cone and plate flow devices are another type of devices used to expose platelets to uniform and 
well-defined shear rates (Figure 2c) [38,48]. To run the assay, a sample of blood or platelet-rich 
plasma is placed between a rotating cone and a stationary well, which exposes the sample to the shear 
rate that is determined by the rotation speed and the angle of the cone [49,50]. Cone and plate flow 
devices have been used to investigate platelet adhesion and aggregation on different ECMs [51–53]. 
More recently, these devices have been used to produce more complicated flow regimes, such as 
pulsatile shear stresses that mimic stenosed regions or recirculation zones [54]. Moreover, these 
devices has been combined with an upright epi-fluorescence microscope to allow for real-time studies 
of the thrombogenecy of biomaterials [55]. One shortcoming of this assay is that the open surface at 
the rotating cone can lead to evaporation of the sample. 
Parallel plate flow chamber is used most frequently among the types of flow perfusion systems 
(Figure 2d) [56,57]. The early design was a channel with a cover-glass holder at the bottom where 
different ECMs could be introduced to the system using a cover-glass that was pre-treated with 
adhesive proteins. After exposure to flowing platelets or whole blood, the cover-glass can be removed, 
fixed, stained, and analyzed for the platelet adhesion and thrombus formation [58]. Later with the 
usage of new imaging techniques, channels were made of clear and thinner materials to allow for a 
microscope objected to be close enough for live-microscopy studies of platelet adhesion and thrombus 
formation [11,22]. An advantage of parallel plate flow chambers over the other devices is that they can 
be modified to mimic different in vivo conditions; among these, pulsatile flow [59] and disturbed  
flow [60] can be generated with a slight modifications to pumping system or flow chamber design. 
Porous membranes can also be used instead of cover-glass to allow for controlled introduction of 
chemicals to the system through the membrane [61]. These membranes help to mimic the release of 
different chemicals from endothelial cells such as agonists and anticoagulants. One limitation with 
parallel plate flow chambers is the use of anti-coagulated blood in these studies; to overcome this 
limitation, these chambers have also been used ex vivo by surgically inserting them into the subject’s 
body in order to study the thrombogenic characteristics of grafts and stents [62]. Parallel plate flow 
chambers have been very successful in determining many of the unknowns in platelet adhesion and 
aggregate formation, including the effect of shear on platelet-ECM binding mechanisms as well as clot 
formation and stability [7,10,11,21,22,63,64].  Int. J. Mol. Sci. 2011, 12                 
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2.2. Microfluidic Devices 
Miniaturized versions of parallel plate flow chambers have been developed to improve the   
micro-and nano-scale capabilities for studying platelets under shear flow [65,66]. These microfluidic 
devices are typically made of a silicone rubber (polydimethylsiloxane, PDMS), which can be cast 
against a silicon master to replicate its features [67]. This process is referred to as soft lithography and 
allows for high precision in replicating micro- and nano-scale features that have been built onto a 
master silicon wafer using processing tools for semiconductor fabrication [68]. To build the 
microfluidic devices, multiple layers of PDMS are bonded together, where each layer contains a part of 
the design of channels and posts [69]. This method is quite versatile and a variety of unique and 
creative chamber configurations have been achieved. 
Microfluidic devices have been used in biological studies because they have the capability to mimic 
the in vivo conditions closely. They have been used effectively in vascular research studies, e.g., shear 
flow mechanotransduction, cell-cell interactions, cell migration, and targeted drug delivery [70,71].  
In particular, they have been used to confirm the observations made using conventional flow devices, 
but at the same time, they provide powerful insights into the interactions between platelet receptors 
and matrix ligands under different shear rates [10,12,72]. Additionally, they have been used to study 
clot formation and the role of different agonists [73], anticoagulants [74], strain micro-circulation 
zones [75] (Figure 3). 
These devices have been able to successfully resolve one of the major short comings of 
conventional flow chambers, which is the high volume consumption of sample blood and reagents. 
Human subjects provide adequate volumes of sample blood to run assays using parallel plate flow 
chambers, but in some cases, a sample volume of blood is limited, e.g., sickle cell anemia. Blood from 
mice, which is advantageous for studying genetic modification, has major limitations in sample volume 
since an average-sized adult mouse can yield less than 1 mL of blood volume [76]. In comparison, 
microfluidic devices require lower volumes of sample blood, usually less than 50 µL [73,77–79]. The 
lower volumes possible with microfluidics have expanded the studies on platelets from knock-out mice, 
which in turn have provided more insights on the role of platelet receptors in adhesion and   
aggregation [79,80]. 
Microfluidic devices have also been helpful in running assays at different shear rates [81]. A variety 
of environments can be introduced under these shear rates, using patterning techniques to create 
wound-like environments with well-defined areas of adhesive protein (Figure 3a) [77]. They have 
enabled studies on aggregate formation to be run with multiple experiments simultaneously   
(Figure 3b) [74,82] or with controlled concentration of agonists (Figure 3c) [73]. Of particular 
noteworthiness, a novel microfluidic device has been used to investigate aggregate formation after 
exposure to micro-gradients in the shear rate (Figure 3d) [24,75]. In these studies, the walls of the 
microchannel were built with a section that narrowed and then expanded in width as the flow passed 
over an obstruction in the channel. This configuration was used to generate a gradient in the shear rate 
that was similar to what platelets experienced as they pass through a stenosis in vivo. Changes in the 
shear rate were able to initiate platelet adhesion and aggregation, even when the platelet response to 
conventional agonists was blocked. The implications of these studies suggest that biomechanical 
factors can activate platelets independent of biochemical factors. I
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cup that holds the sample and is rotated back and forth by a small angle. A pin is suspended in the 
blood sample and is normally stationary, but when fibrin strands and platelet adhesions formed, the 
torque from the rotating cup is transferred to the pin, which then rotates. The strength of these fibrin 
strands and platelet forces affect the motion of the pin. Its rotation is measured by a transducer   
and reported as the output of the system. Key information obtained by thromboelastography consists of 
the initiation of coagulation, propagation kinetics, fibrin-platelet interaction, clot firmness, and 
fibrinolysis [93]. The main shortcomings of this method, however, are its sensitivity to mechanical 
vibrations and long assay time in the absence of chemical agonists. To address these shortcomings a 
variation of this method called rotating thromboelastography (ROTEM) has been designed which 
transmits the pin signal through an optical detector and the movement is initiated by the pin [95]. This 
technique is considered a whole blood coagulation assay and is used to predict surgical bleeding and 
aid to determine blood product usage for a patient clinically [91].  
Platelet clot strips was the first technique to directly examine contractile forces within the clots 
(Figure 4d). Clot strips are formed by pouring platelet-rich plasma into a cylindrical tube and 
activating them with thrombin or heating up the clots [96–98]. After removing the clots strip from the 
tube, one end is tied to a rigid support and the other is tied to a load cell which monitors the retraction 
force in the sample. This technique has been used to study the effect of different agonists on the 
tension generated in a clot [96], receptors involved in fibrin-platelet binding [99], and alignment of 
fibrin in the clot contraction [97]. The positive aspect of this method is that since the assays are done in 
a fluid bath, it is possible to change the conditions of the experiment by changing the bath solution. Its 
shortcoming, however, is that the clot needs to be directly manipulated when it is mounted onto the 
load cell, resulting in mechanical disruption of the fibrin-platelet adhesions which can compromise the 
testing results. 
Clot retractometry examines platelet clots by directly forming them between a cup and plate which 
is coupled to a strain gauge transducer with a voltage output (Figure 4e) [100,101]. The plate is in 
contact with the blood sample and during clotting, fibrin strands as well as platelet aggregates connect 
the cup and plate. Once clots are formed, platelets forces pull on the fibrin strands, which in turn pull 
down on the plate. This movement is then transferred to a load cells that reports the output of the 
system. The advantage that this method over others is that it allows for measurement of the force at the 
onset of clot formation and does not require additional physical handling of the growing clot. Clot 
retractometry has been used extensively to investigate the clinical relevance of platelet forces in 
cardiovascular disease and medical treatments [101–110]. 
3.2. Micro/Nano Force Assays 
Conventional force measurement techniques discussed here have been successful in demonstrating 
the importance of platelet forces in hemostasis. There is, however, an inherent size and resolution 
limitation within these methods. Platelet cytoskeleton-fibrin interactions are nanoscale and complex 
with glycoprotein receptors playing different roles in adhesion, aggregation, and clot retraction. The 
macro-scale dimensions of the conventional techniques do not allow for microscopic imaging, which 
can help reveal the dynamic features of thrombus formation. Moreover, the fibrin meshwork has 
strain-stiffening behavior under load, which confounds the direct measurement of platelet forces. Int. J. Mol. Sci. 2011, 12                 
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Therefore, researchers have begun to explore tools that come from micro- and nano-scale technologies 
in order to gain more insight into the mechanobiology of platelets.  
Micropost arrays are a novel microscale force sensor that have been used previously to measure 
cellular traction forces [111,112]. This sensor is an array of micro-size, flexible, vertical posts that 
bend in proportion to the forces that cells apply at tips of the posts. The posts are made from PDMS 
using soft lithography, similar to the fabrication of microfluidic devices. These arrays have been used 
to study cell migration [112], cell spreading [111], and traction forces [111,113–118]. Forces within 
monolayers [112,119–122] as well as tissue constructs [123], and cell-cell forces [124,125] have also 
been examined using this tool. At the same time a variety of cell studies have been done using   
different types of cells, such as fibroblasts [111,116,117,126,127], smooth muscle cells [111,128], 
cardiomyocytes [129,130], epithelial cells [115,126], endothelial cells [128], and stem cells [114,131]. 
Micropost arrays are considered a novel tool for cell mechanic studies because they can be used to map 
the traction forces of cells spread over multiple posts. Additionally, live studies are possible with 
microposts to investigate the dynamics of cytoskeletal force development. The unique property of this 
sensor is that it can be bio-functionalized with different adhesive proteins to study specific   
receptor-ligand interactions. Micropost arrays have been recently used to investigate platelet forces  
in more detail (Figure 5a). The arrays have been used to examine the effect of concentration of 
thrombin on contractile forces of platelet aggregates as well as the adhesive interactions with 
fibronectin and fibrinogen [26]. Comparisons also have been done between quasi-static and live 
imaging of aggregate formation to show its spatio-temporal capability in assessing platelet 
functionality and thrombus formation. 
Atomic force microscopy ( AFM) is another technique that is typically used for nano-scale 
characterization of materials, but it has been adapted to study the mechanical properties of cells and 
single molecules [132]. AFM uses a flexible tip that acts like a cantilever to measure forces in the 
vertical direction. The deflection of the tip is measured from a laser beam that is reflected off the back 
of the tip and towards an array of photodiode detectors. AFMs have been used to investigate cell 
mechanics and cytoskeletal elasticity [133–140] as well as cell-cell forces [141–143], receptor-ligand 
dynamic interactions [141,144], and cytoskeletal proteins [145,146]. Recently, AFM has been used to 
study the nature of the ligand-receptor bond between vWF and GPIbα in platelets. Platelet adhesion to 
the vessel wall likely involves catch-bonds between vWF and GPIbα because high shear stress leads to 
greater binding [147]. This observation is similar to the catch bond-like behavior in other integrin 
types where the strength of the bond increases with the applied external force [148,149]. Using an 
AFM, the bond lifetime of a GPIbα-coated tip to a surface coating of vWF A1-domain was confirmed 
to have catch-bond behavior because the lifetime of the bond increased up to a peak load value   
and then reduced at higher loads as the catch-bond transitioned to a slip-bond [150]. Another 
significant study done using AFM was the direct measurement of retraction forces from a single 
platelet (Figure 5b) [27]. The AFM tip was integrated with a fluorescence microscope and the tip was 
coated with fibrinogen. This technique was not only able to measure the contractile force of single 
platelet, but it was also able to use AFM tips of different spring-constants to show that platelet regulate 
their retraction forces in proportion to the stiffness of the surround clot structure. These findings 
indicate that clot stiffening happens through the contraction of platelets as well as by the strain-stiffening 
of fibrin strands under the tension generated by platelet forces.  I
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Micro/nano devices can provide new capabilities in studying platelets and hemostasis. They 
represent a programmable environment that can be modified to represent different in vivo conditions 
like shear, stiffness, or agonist concentration. Moreover, it may be possible to integrate the 
biomechanical assays that measure platelet forces with microfluidic devices in order to study the 
transitions from adhesion, aggregation, and clot retraction while also subjecting platelets to the 
biomechanical and biochemical triggers that occur in vivo. These types of assays can become useful 
for studies on genetic defects that affect the mechanobiology of platelets. Mutations in the GPIb-IX-V 
complex (Bernard-Soulier syndrome), integrin αIIbβ3 (Glanzmann thrombasthenia), or the MYH9 gene 
that encodes the heavy chain of nonmuscle myosin IIA (May-Hegglin anomaly, Fechtner, Epstein, and 
Sebastian syndromes) can lead to serious bleeding disorders due to impaired adhesion, aggregation, or 
clot stability [155,156]. Biomechanical assays for platelets can help diagnose these clinical conditions 
and can open the door to new treatments for improved hemostasis. 
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